Trial site
Klaipedos universiteto ligonine VšĮ
- 21running trials
- 14closed trials
The trials here
What the 35 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis6 trials
- Multiple sclerosis4 trials
- Psoriatic arthritis4 trials
- Melanoma3 trials
- Gastric and oesophageal cancer2 trials
- Heart failure2 trials
- Psoriasis2 trials
- Atrial fibrillation1 trial
- Bladder cancer1 trial
- Chronic kidney disease1 trial
- Chronic lymphocytic leukaemia1 trial
- Deep vein thrombosis and pulmonary embolism1 trial
- and 12 more
- Phase
- Phase 324 trials
- Phase 210 trials
- Phase 11 trial
- Status
- Completed14 trials
- Active, not recruiting12 trials
- Recruiting5 trials
- Not yet recruiting4 trials
- Lead sponsor
- AbbVie3 trials
- H e x a l AG3 trials
- argenx2 trials
- MoonLake Immunotherapeutics AG2 trials
- Novo Nordisk A/S2 trials
- and 22 more
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Enrolling by invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Recruiting
Not yet recruiting
Recruiting
Active, not recruiting
A study to test if SRSD107 prevents venous thromboembolism events and how safe it is
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Guselkumab in Participants With Active Psoriatic Arthritis
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ulcerative colitis3 recruiting
- Graves' disease1 recruiting
- Heart failure1 recruiting
- High blood pressure1 recruiting
- Multiple sclerosis1 recruiting
- Prostate cancer1 recruiting
- Psoriatic arthritis1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Active, not recruiting
Completed
Completed
Completed
Terminated
A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis
Completed
Completed
Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
Completed
Completed
Completed
Completed
Completed
Completed
Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026